Filing Details

Accession Number:
0001562180-19-005398
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-07 16:55:49
Reporting Period:
2019-11-05
Accepted Time:
2019-11-07 16:55:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1271214 Intersect Ent Inc. XENT Surgical & Medical Instruments & Apparatus (3841) 200280837
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614476 Jr H Robert Binney C/O Intersect Ent, Inc.
1555 Adams Drive
Menlo Park CA 94025
Chief Commercial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-05 4,687 $21.06 29,036 No 4 M Direct
Common Stock Acquisiton 2019-11-05 9,375 $18.90 38,411 No 4 M Direct
Common Stock Acquisiton 2019-11-05 7,875 $13.05 46,286 No 4 M Direct
Common Stock Disposition 2019-11-05 25,584 $21.54 20,702 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-11-05 4,687 $0.00 4,687 $21.06
Common Stock Stock Option (right to buy) Disposition 2019-11-05 9,375 $0.00 9,375 $18.90
Common Stock Stock Option (right to buy) Disposition 2019-11-05 7,875 $0.00 7,875 $13.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-01-20 No 4 M Direct
1,042 2026-01-14 No 4 M Direct
7,000 2027-01-17 No 4 M Direct
Footnotes
  1. Includes 20,702 restricted stock units and 500 Shares purchased on 5/15/2019 with ESPP plan.
  2. Includes 20,702 restricted stock units.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.106 to $21.76, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
  4. The vesting commencement date of the option was January 1st, 2015. 1/8th of the shares subject to the option vested on July 1st, 2015 and 1/48th of the shares subject to the option vests monthly thereafter over 42 months.
  5. The shares subject to the option vests monthly over four years commencing on January 1st, 2016.
  6. The vesting commencement date of the option was March 1st, 2017. 1/8th of the shares subject to the option vested on September 1st, 2017 and 1/48th of the shares subject to the option vests monthly thereafter over 42 months.